Wen‐Pang Su

513 total citations
29 papers, 369 citations indexed

About

Wen‐Pang Su is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Wen‐Pang Su has authored 29 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 21 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Wen‐Pang Su's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (12 papers). Wen‐Pang Su is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (12 papers). Wen‐Pang Su collaborates with scholars based in Taiwan, Germany and United Kingdom. Wen‐Pang Su's co-authors include Cheng‐Yuan Peng, Hsueh‐Chou Lai, Po‐Heng Chuang, Sheng‐Hung Chen, Hung‐Wei Wang, Wei‐Fan Hsu, Guan‐Tarn Huang, Chia‐Hsin Lin, I‐Ping Chiang and Jane Pei‐Chen Chang and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Wen‐Pang Su

26 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen‐Pang Su Taiwan	13	259	224	49	45	30	29	369
Katsuhiko Fukuda Japan	12	240 0.9×	217 1.0×	47 1.0×	25 0.6×	19 0.6×	23	428
Diarmuid Manning Ireland	7	295 1.1×	330 1.5×	70 1.4×	14 0.3×	20 0.7×	10	436
Astrid Scalori United Kingdom	9	170 0.7×	122 0.5×	67 1.4×	24 0.5×	20 0.7×	25	286
Tom Creed United Kingdom	9	29 0.1×	123 0.5×	48 1.0×	31 0.7×	26 0.9×	21	330
Shou–Dong Lee Taiwan	6	550 2.1×	538 2.4×	65 1.3×	25 0.6×	1 0.0×	6	672
Xiaofeng Sun China	11	59 0.2×	95 0.4×	38 0.8×	54 1.2×		21	349
J. Florholmen Norway	11	40 0.2×	80 0.4×	97 2.0×	32 0.7×	5 0.2×	16	259
Efthymios P. Tsounis Greece	9	29 0.1×	83 0.4×	30 0.6×	15 0.3×	7 0.2×	22	245
Savit B. Prabhu India	7	59 0.2×	38 0.2×	16 0.3×	22 0.5×	4 0.1×	17	249
Gema M. Lledó Spain	10	113 0.4×	119 0.5×	16 0.3×	10 0.2×	2 0.1×	24	304

Countries citing papers authored by Wen‐Pang Su

Since Specialization

Citations

This map shows the geographic impact of Wen‐Pang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Pang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Pang Su more than expected).

Fields of papers citing papers by Wen‐Pang Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Pang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Pang Su. The network helps show where Wen‐Pang Su may publish in the future.

Co-authorship network of co-authors of Wen‐Pang Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Pang Su. A scholar is included among the top collaborators of Wen‐Pang Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Pang Su. Wen‐Pang Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Sheng‐Hung, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2024). Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals. Journal of the Formosan Medical Association. 123(12). 1279–1286.

Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2024). Trajectories and Decline of Serum Hepatitis B Surface Antigen Predict Outcomes in Patients With Chronic Hepatitis B. Open Forum Infectious Diseases. 11(12). ofae699–ofae699.

Wang, Hung‐Wei, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2024). Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 15(5). 2216–2229.

Wang, Hung‐Wei, Chi-Yi Chen, Hsueh‐Chou Lai, et al.. (2023). Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy.. PubMed. 13(2). 526–537. 2 indexed citations

Hsu, Wei‐Fan, Hsueh‐Chou Lai, Po‐Heng Chuang, et al.. (2022). Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents. Journal of Viral Hepatitis. 29(9). 785–794. 4 indexed citations

Wang, Hung‐Wei, Wen‐Pang Su, Wei‐Fan Hsu, et al.. (2021). On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 13(15). 3758–3758. 12 indexed citations

Lin, Mei‐Chen, Shih‐Wei Lai, Chung‐Kang Peng, et al.. (2021). Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan. World Journal of Hepatology. 13(11). 1766–1776. 2 indexed citations

Liu, Chen‐Hua, Cheng‐Yuan Peng, Yu‐Jen Fang, et al.. (2020). Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific Reports. 10(1). 9180–9180. 8 indexed citations

Su, Kuan‐Pin, Hsueh‐Chou Lai, Cheng‐Yuan Peng, et al.. (2019). Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder. Brain Behavior and Immunity. 80. 512–518. 49 indexed citations

10.

Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2019). Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents. BMC Gastroenterology. 19(1). 63–63. 45 indexed citations

11.

Lee, Chuan‐Mo, Tsung‐Hui Hu, Chao‐Hung Hung, et al.. (2018). A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver International. 38(11). 1997–2005. 12 indexed citations

12.

Chen, Sheng‐Hung, Hsueh‐Chou Lai, I‐Ping Chiang, et al.. (2018). Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C. PLoS ONE. 13(1). e0190455–e0190455. 22 indexed citations

13.

Wang, Hung‐Wei, Hsueh‐Chou Lai, Tsung‐Hui Hu, et al.. (2018). Stratification of hepatocellular carcinoma risk through modified FIB‐4 index in chronic hepatitis B patients on entecavir therapy. Journal of Gastroenterology and Hepatology. 34(2). 442–449. 11 indexed citations

14.

Hsu, Wei‐Fan, Hsueh‐Chou Lai, Wen‐Pang Su, et al.. (2017). Trajectories of serum hepatitis B surface antigen kinetics in patients with chronic hepatitis B receiving long‐term nucleos(t)ide analogue therapy. Liver International. 38(4). 627–635. 4 indexed citations

15.

Chen, Sheng‐Hung, Cheng‐Yuan Peng, I‐Ping Chiang, et al.. (2016). Comparison of collagen proportionate areas in liver fibrosis quantification between chronic hepatitis B and C. Medicine. 95(35). e4736–e4736. 8 indexed citations

16.

Chen, Sheng‐Hung, Cheng‐Yuan Peng, Hsueh‐Chou Lai, et al.. (2015). Head-to-Head Comparison between Collagen Proportionate Area and Acoustic Radiation Force Impulse Elastography in Liver Fibrosis Quantification in Chronic Hepatitis C. PLoS ONE. 10(10). e0140554–e0140554. 13 indexed citations

17.

Jeng, Long-Bin, Horng-Ren Yang, Chun‐Chieh Yeh, et al.. (2012). Hepatic Artery Reconstruction in Living Donor Liver Transplantation: Running Suture Under Surgical Loupes by Cardiovascular Surgeons in 180 Recipients. Transplantation Proceedings. 44(2). 448–450. 15 indexed citations

18.

Jeng, Long-Bin, Horng-Ren Yang, Chun‐Chieh Yeh, et al.. (2012). A High Model for End-stage Liver Disease Score Should Not Be Considered a Contraindication to Living Donor Liver Transplantation. Transplantation Proceedings. 44(2). 316–319. 15 indexed citations

19.

Chen, Sheng‐Hung, Yufen Li, Hsueh‐Chou Lai, et al.. (2012). Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C. BMC Gastroenterology. 12(1). 105–105. 44 indexed citations

20.

Yang, Horng-Ren, Long‐Bin Jeng, Hsueh‐Chou Lai, et al.. (2012). Living Donor Right Hepatectomy With Inclusion of the Middle Hepatic Vein: Outcome in 200 Donors. Transplantation Proceedings. 44(2). 460–462. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact